SCHEMBL13643176

SCHEMBL13643176

c1ccc(-c2cc(-c3ccccc3)c3cc(-c4ccc(-c5cc(-c6ccccc6)c6ccccc6n5)cc4)c4ccccc4c3n2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACA Q13085 5/20 0.63
HPGD P15428 3/20 0.58
KDM4E B2RXH2 3/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
MAPK1 P28482 2/20 0.58
TDP1 Q9NUW8 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
ACHE P22303 1/20 0.53
TOP1 P11387 4/20 0.53
LMNA P02545 4/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
DHODH Q02127 1/20 0.50
PDE10A Q9Y233 1/20 0.49
MEN1 O00255 1/20 0.47
RECQL P46063 1/20 0.47
KMT2A Q03164 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
AURKA O14965 1/20 0.46
AURKB Q96GD4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13643002 1.00 ACACA (0.63) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13642862 1.00 ACACA (0.63) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13643100 0.98 ACACA (0.61) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13642958 0.98 ACACA (0.61) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13083883 0.98 ACACA (0.61) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13083932 0.93 ACACA (0.56) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13642922 0.91 ACACA (0.55) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13642942 0.91 ACACA (0.58) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13643156 0.91 ACACA (0.55) ACACAHPGDKDM4EALDH1A1MAPT
SCHEMBL13083955 0.91 ACACA (0.55) ACACAHPGDKDM4EALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-8796917-B2 Compound for an organic optoelectronic device, organic light emitting diode including the same, and display including the organic light emitting diode CHEIL INDUSTRIES, INC (KR) 2014-08-05 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE CHEIL INDUSTRIES, INC. (KR) 2012-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120280613-A1 COMPOUND FOR AN ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY INCLUDING THE ORGANIC LIGHT EMITTING DIODE OR51E2, AOX1, OR10J3 ACACA 2421/4885HPGD 2437/4885KDM4E 3229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.